These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3245176)

  • 1. [Rifampicin pharmacokinetics in patients with destructive pulmonary tuberculosis].
    Karkishchenko NN; Vorob'ev VS; Khoron'ko VV; Anisimova NB; Chubarian VT
    Vrach Delo; 1988 Dec; (12):72-3. PubMed ID: 3245176
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intravenous rifampicin therapy in open tuberculosis].
    Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
    Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
    Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
    Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum concentration of isoniazid following administration of the drug alone and in combination with rifampicin in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Kishore K; Varshney SC; Varshney DP
    Indian J Physiol Pharmacol; 1986; 30(1):115-7. PubMed ID: 3818028
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1106-11. PubMed ID: 19723399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corrective possibilities of rifampicin in ineffective chemotherapy of destructive pulmonary tuberculosis in children and adolescents].
    Ivaniuta OM; Il'nitskiĭ IG; Panasiuk AV; Kunichkina SA
    Probl Tuberk; 1987; (8):30-3. PubMed ID: 3684986
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin-aluminium antacid interaction.
    Gupta PR; Mehta YR; Gupta ML; Sharma TN; Jain D; Gupta RB
    J Assoc Physicians India; 1988 Jun; 36(6):363-4. PubMed ID: 3182711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration].
    Sagalovich VIa; Manzhikova SR
    Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complex therapy of newly detected patients with destructive pulmonary tuberculosis using rifampicin and tuberculin].
    Reĭle EE; Polushkina EE
    Probl Tuberk; 1987; (2):22-5. PubMed ID: 3575271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inactivation of glucocorticoid hormones by rifampicin in the treatment of patients with pulmonary tuberculosis].
    Spesivtsev OG; Basov PV
    Probl Tuberk; 1988; (12):27-8. PubMed ID: 3244680
    [No Abstract]   [Full Text] [Related]  

  • 11. [The inactivation of glucocorticosteroid hormones by rifampicin when it is used intermittently].
    Basov PV; Prokhorov NN; Spesivtsev OG
    Vrach Delo; 1990 Nov; (11):20-2. PubMed ID: 2098973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis.
    Peloquin CA; Maslow JN; Mikota SK; Forrest A; Dunker F; Isaza R; Peddie LR; Peddie J; Zhu M
    J Vet Pharmacol Ther; 2006 Dec; 29(6):581-5. PubMed ID: 17083464
    [No Abstract]   [Full Text] [Related]  

  • 15. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis].
    Ursov IG; Krasnov VA; B1tashova VA; Kudelia OA; Volkova ZhA; Gromyko NI; Borovinskaia TA
    Probl Tuberk; 1998; (4):21-2. PubMed ID: 9771031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis].
    Sodikov ES; Abrarov BA
    Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a Soviet preparation of rifampicin for intravenous injection in the treatment of patients with destructive tuberculosis of the lungs].
    Ivaniuta OM; Panasiuk AV; Il'nitskiĭ IG; Davyda RS; Kunichkina SA
    Vrach Delo; 1985 Nov; (11):32-4. PubMed ID: 4082545
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.